Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hydreight Technologies Inc ( (TSE:NURS) ) has provided an announcement.
Hydreight Technologies Inc. reported record growth in its VSDHOne platform, surpassing internal projections with over 80,000 pharmacy and telehealth product orders in August 2025. The company has seen significant expansion in its nurse network and pharmacy orders, contributing to a 33% year-over-year revenue growth for the first half of 2025. Strategic initiatives include an oversubscribed $11.5 million financing, acquisition of a stake in Perfect Scripts LLC, and plans to integrate AI technology to enhance service offerings. These efforts aim to strengthen Hydreight’s market position, improve operational efficiency, and expand its total addressable market.
The most recent analyst rating on (TSE:NURS) stock is a Buy with a C$8.50 price target. To see the full list of analyst forecasts on Hydreight Technologies Inc stock, see the TSE:NURS Stock Forecast page.
More about Hydreight Technologies Inc
Hydreight Technologies Inc. operates in the healthcare industry, offering a mobile clinical network powered by a proprietary telehealth platform, pharmacy network, and medical director network across the United States. The company focuses on providing services such as IV therapy, hormone optimization, and preventive testing, catering to some of the fastest-growing segments of the U.S. healthcare market.
Average Trading Volume: 345,177
Technical Sentiment Signal: Buy
Current Market Cap: C$115.8M
See more insights into NURS stock on TipRanks’ Stock Analysis page.